Imunon, Inc. (IMNN): Shareholders' Equity
$7.06M
As of 2025-12-31
$4.19M
As of 2026-06-30
-37.8%
3-year compound annual growth
-17.6%
5-year compound annual growth
-10.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.06M | +66.4% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $4.24M | -68.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $13.39M | -54.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $29.33M | -47.4% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $55.80M | +199.8% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $18.61M | +27.8% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $14.56M | -30.2% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $20.86M | -21.9% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $26.70M | +297.0% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $6.73M | -67.0% | 2018-03-27, Balance as of period end |
| 2015-12-31 | $20.39M | -37.9% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $32.83M | +4.1% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $31.52M | +163.5% | 2016-03-30, Balance as of period end |
| 2012-12-31 | $11.96M | -54.3% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $26.19M | n/m | 2014-03-13, Balance as of period end |
| 2010-12-31 | -$4.58M | n/a | 2013-03-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | $7.06M | +66.4% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $4.69M | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $11.66M | +205.8% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $9.66M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$15.94M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $8.86M | +88.2% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.22M | n/m |
Compare IMNN, TTRX, ANEB, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗